Biotechnology companies have a major focus on R&D and the potential for developing highly specialised products. In recent times this has been a dynamic sector, with companies looking to secure long-term funding, enticing investors with the potential for substantial returns.
Biotechnology offers a route for enhancing the sustainability and renewability of certain chemical processes. It involves the utilisation of living things as a manufacturing tool to create useful products. Biological processes can use optimised enzymes, microorganisms, and cells to produce fuels, food, vaccines, and many other vital manufactured goods.
These are some of the key sectors of the Biotechnology (Biotech) industry in which Natrium Capital has expertise:
Natrium Capital has extensive understanding of companies with new and developing technologies and has established relationships with leading scientific advisors in the Biotechnology sector.
Read more about our specific skills in this sector.
Drawing on the local market expertise of our international partners, Natrium Capital has significant global reach.